Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022

SELL
$9.99 - $20.49 $99,900 - $204,899
-10,000 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$18.34 - $21.0 $4.4 Million - $5.04 Million
-240,000 Reduced 96.0%
10,000 $196,000
Q2 2021

Aug 12, 2021

BUY
$19.25 - $21.01 $4.81 Million - $5.25 Million
250,000 New
250,000 $5.12 Million

Others Institutions Holding MOLN

About MOLECULAR PARTNERS AG


  • Ticker MOLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,514,000
  • Market Cap $169M
  • Description
  • Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...
More about MOLN
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.